ESC
IDXX icon

Eurizon SLJ Capital’s Idexx Laboratories IDXX Stock Holding History

Eurizon SLJ Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Sell
3,720
-2,920
-44% -$1.64M 0.72% 29
2026
Q1 		$3.7M Sell
6,640
-1,845
-22% -$1.18M 1.76% 18
2025
Q4 		$5.74M Buy
+8,485
New +$5.78M 2.27% 16

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Eurizon SLJ Capital's IDXX Position: Q2 2026 in Review

Eurizon SLJ Capital reduced its Idexx Laboratories (IDXX) stake by 44% in Q2 2026, selling an estimated $1.64M and leaving 3,720 shares worth $1.96M. The position accounts for 0.72% of the portfolio, ranked #29.

Eurizon SLJ Capital first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.74M in Q4 2025. 1,297 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Eurizon SLJ Capital held 3,720 shares of Idexx Laboratories worth $1.96M as of Q2 2026.
  • Eurizon SLJ Capital sold 2,920 Idexx Laboratories shares in Q2 2026, an estimated $1.64M.
  • Idexx Laboratories made up 0.72% of Eurizon SLJ Capital's portfolio in Q2 2026, its #29 holding.
  • Eurizon SLJ Capital first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Eurizon SLJ Capital's Idexx Laboratories position peaked at $5.74M in Q4 2025.
  • 1,297 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Eurizon SLJ Capital's 13F filing for Q2 2026, filed 3 Aug 2026.